| Target Price | $31.62 |
| Price | $19.71 |
| Potential |
60.43%
register free of charge
|
| Number of Estimates | 20 |
|
20 Analysts have issued a price target Privia Health Group 2027 .
The average Privia Health Group target price is $31.62.
This is
60.43%
register free of charge
$42.00
113.09%
register free of charge
$24.24
22.98%
register free of charge
|
|
| A rating was issued by 25 analysts: 23 Analysts recommend Privia Health Group to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2027 of
60.43%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.12 | 2.50 |
| 22.26% | 17.96% | |
| EBITDA Margin | 2.08% | 6.21% |
| 48.88% | 198.66% | |
| Net Margin | 1.08% | 1.35% |
| 30.28% | 25.04% |
20 Analysts have issued a sales forecast Privia Health Group 2026 . The average Privia Health Group sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an Privia Health Group EBITDA forecast 2026. The average Privia Health Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Privia Health Group Analysts have issued a net profit forecast 2026. The average Privia Health Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.18 | 0.27 |
| 63.64% | 50.00% | |
| P/E | 73.80 | |
| EV/Sales | 0.84 |
21 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group EPS is
This results in the following potential growth metrics and future valuations:
Privia Health Group...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | May 26 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 08 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Apr 08 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Mar 25 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 03 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
May 26 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 08 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Apr 08 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Mar 25 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 03 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Mar 02 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 27 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


